LecturesL01.01NO ABSTRACT AVAILABLEL01.02NO ABSTRACT AVAILABLEL02.01DEVELOPMENT OF MPDL3280A, AN ANTI-PD-L1 ANTIBODY ENGINEERED FOR ENHANCED EFFICACY AND SAFETYL02.02NO ABSTRACT AVAILABLEL02.03NIVOLUMAB (ANTI-PROGRAMMED DEATH-1 [PD-1]; BMS-936558) IN PATIENTS (PTS) WITH ADVANCED SOLID TUMORS: ...